FACTORS ASSOCIATED WITH FATTY LIVER DISEASE AND SELF-MANAGEMENT STRATEGIES AMONG DIAGNOSED PATIENTS IN SELECTED TEACHING HOSPITALS IN OGUN STATE, NIGERIA
DOI:
https://doi.org/10.48047/jpn16j55Keywords:
: Fatty Liver Disease, Socio-demographic, Self-management StrategiesAbstract
This study assessed the factors associated with Fatty Liver Disease and self-management strategies among diagnosed patients in selected teaching hospitals in Ogun State, Nigeria. A cross sectional descriptive design was utilized for the study using a sample of 244 diagnosed patients. A structured and validated questionnaire was used at both BUTH and OOUTH respectively. Data was analyzed using descriptive, and Chi-square statistics at 5% level of significance. The findings showed that most respondents were between 50–60 years (37.3%), female (54.5%), and had secondary school education (33.6%). About 35.2% had been diagnosed within six months and 47.5% discovered the condition during routine check-ups. Additionally, the chi-square value obtained for level of education is (x2 = 71.803, p = .000 < .05); religion (x2 = 39.999, p = .000 < .05); ethnicity (x2 = 26.345, p = .000 < .05); average monthly Income (x2 = 30.009, p = .000 < .05); duration of diagnosis (x2 = 21.087, p = .017 < .05); and family member been diagnosed (x2 = 18.876, p = .000 < .05) were significant at less than 0.05. Also, there is a significant relationship between perceived severity of fatty liver disease and self-management strategies among diagnosed patients (x2 = 53.269, p = .000 < .05). The study concluded that patient education and awareness are crucial for successful self-management. Additionally, the community, family, and medical professionals' support increases treatment plan acceptance and adherence, which inevitably raises overall quality of life.
Downloads
References
Anstee, Q.,Targher, G., & Day, C. P. (2020).Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.Nature Reviews Gastroenterology & Hepatology,10(6), 330-344.
Buzzetti, E.,Pinzani, M., &Tsochatzis, E., (2019).The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).Metabolism, 65(8), 1038-1048.
Carpenter, C., (2021).A meta-analysis of the effectiveness of health belief model variables in predicting behavior. Health Communication, 25(8), 661-669.
Chalasani, N., Younossi, Z., Lavine, J., Diehl, A., Brunt, E., Cusi, K., ...&`Sanyal, A. J., (2020). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology,67(1), 328-357.
Friedman, S., Neuschwander-Tetri, B., Rinella, M., &Sanyal, A., (2021).Mechanisms of NAFLD development and therapeutic strategies.Nature Medicine, 24(7), 908-922.
Hashida, R., Kawaguchi, T., Bekki, M., Omoto, M., Matsuse, H., Nago, N., ...&Kumagi, T. (2020). Aerobic vs. resistance exercise in improving liver fat content in NAFLD: A randomized clinical trial. Journal of Hepatology, 66(1), 142-152
Le, M., Devaki, P., Ha, N., Jun, D., Te, H., Cheung, R., & Nguyen, M., (2019).Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS One, 14(4), e0215326.
Lonardo, A., Ballestri, S., Guaraldi, G., Nascimbeni, F., Romagnoli, D., &Targher, G. (2020).NAFLD and gender: gender differences in the clinical phenotypes of NAFLD. Hepatology, 70(4), 1456-1465.
Mantovani, A., Scorletti, E., Mosca, A., Alisi, A., Byrne, C., &Targher, G., (2020). Complications, morbidity and mortality of nonalcoholic fatty liver disease.Metabolism, 111, 154815.
Rich, N., Oji, S., Mufti, A., Browning, J., Parikh, N., &Odewole, M., (2022).Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence.Gastroenterology, 155(3), 882-890.
Vander Windt, D., Sud, V., Zhang, H., Tsung, A., & Huang, H., (2020). The effects of stress on liver function.Surgical Clinics, 97(4), 779-791.
West, D., Greene, P., Pulley, L., Kratt, P., Gore, S., Weiss, H., &Laken, M., (2020). A motivation-focused weight loss maintenance program is an effective alternative to standard behavioral interventions. Journal of Consulting and Clinical Psychology, 76(2), 203-213.
Yki-Järvinen H. (2021) "Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome."The Lancet Diabetes & Endocrinology.
Younossi, Z., Henry, L., Bush, H., & Mishra, A., (2021). Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Clinics in Liver Disease, 20(2), 205-214.
Zelber-Sagi, S., Ivancovsky-Wajcman, D., &Fliss-Isakov, N.,(2021). High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. Journal of Hepatology, 70(5), 917-925.
Zhou, J., Zhou, F., Wang, W., Zhang, X., Ji, Y., Zhang, & She, Z. (2019). Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology, 71(5), 1851-1864.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
